nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADME of Biologics—What Have We Learned from Small Molecules?
|
Prueksaritanont, Thomayant |
|
2012 |
14 |
3 |
p. 410-419 |
artikel |
2 |
A Platform for Characterizing Therapeutic Monoclonal Antibody Breakdown Products by 2D Chromatography and Top-Down Mass Spectrometry
|
Mazur, Matthew T. |
|
2012 |
14 |
3 |
p. 530-541 |
artikel |
3 |
A Technique to Estimate In Vivo Dissolution Profiles Without Data from a Solution
|
Cook, Jack A. |
|
2012 |
14 |
3 |
p. 433-436 |
artikel |
4 |
Biopharmaceutic Planning in Pediatric Drug Development
|
Purohit, Vivek S. |
|
2012 |
14 |
3 |
p. 519-522 |
artikel |
5 |
Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products
|
Mitra, Amitava |
|
2012 |
14 |
3 |
p. 646-655 |
artikel |
6 |
Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations
|
Boswell, C. Andrew |
|
2012 |
14 |
3 |
p. 612-618 |
artikel |
7 |
Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid
|
Cullen, Valerie C. |
|
2012 |
14 |
3 |
p. 510-518 |
artikel |
8 |
Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers
|
Adams, Wallace P. |
|
2012 |
14 |
3 |
p. 400-409 |
artikel |
9 |
Effects of Molecular Weight and Loading on Matrix Metalloproteinase-2 Mediated Release from Poly(Ethylene Glycol) Diacrylate Hydrogels
|
Ross, Amy E. |
|
2012 |
14 |
3 |
p. 482-490 |
artikel |
10 |
Fish Drug Analysis—Phish-Pharm: 2011 Update
|
Reimschuessel, Renate |
|
2012 |
14 |
3 |
p. 481 |
artikel |
11 |
Glucocorticoid Receptor-Mediated Transcriptional Regulation of N-acetyltransferase 1 Gene Through Distal Promoter
|
Bonamassa, Barbara |
|
2012 |
14 |
3 |
p. 581-590 |
artikel |
12 |
In vitro–In Vivo Correlations: Tricks and Traps
|
Cardot, J.-M. |
|
2012 |
14 |
3 |
p. 491-499 |
artikel |
13 |
Ligand Binding Assays in the 21st Century Laboratory—A Call for Change
|
Ray, Chad A. |
|
2012 |
14 |
3 |
p. 377-379 |
artikel |
14 |
Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
|
Richter, Wolfgang F. |
|
2012 |
14 |
3 |
p. 559-570 |
artikel |
15 |
Nonclinical Dose Formulation: Out of Specification Investigations
|
Appleton, Troy |
|
2012 |
14 |
3 |
p. 523-529 |
artikel |
16 |
Pain Assessment in Human Fetus and Infants
|
Bellieni, Carlo Valerio |
|
2012 |
14 |
3 |
p. 456-461 |
artikel |
17 |
Paradigm Shift in Toxicity Testing and Modeling
|
Sun, Hongmao |
|
2012 |
14 |
3 |
p. 473-480 |
artikel |
18 |
Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose–Response Models
|
Plan, Elodie L. |
|
2012 |
14 |
3 |
p. 420-432 |
artikel |
19 |
Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses
|
Keizer, Ron J. |
|
2012 |
14 |
3 |
p. 601-611 |
artikel |
20 |
Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts
|
Abuqayyas, Lubna |
|
2012 |
14 |
3 |
p. 445-455 |
artikel |
21 |
Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various Sources
|
Awotwe-Otoo, David |
|
2012 |
14 |
3 |
p. 619-626 |
artikel |
22 |
Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
|
Bumbaca, Daniela |
|
2012 |
14 |
3 |
p. 554-558 |
artikel |
23 |
Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats
|
Westerhout, Joost |
|
2012 |
14 |
3 |
p. 543-553 |
artikel |
24 |
Population Pharmacokinetics and Pharmacodynamics of Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Infection
|
Jin, Runyan |
|
2012 |
14 |
3 |
p. 571-580 |
artikel |
25 |
Predicting the Effects of Anti-angiogenic Agents Targeting Specific VEGF Isoforms
|
Finley, Stacey D. |
|
2012 |
14 |
3 |
p. 500-509 |
artikel |
26 |
Re-introduction of a Novel Approach to the Use of Stable Isotopes in Pharmacokinetic Studies
|
Parr, Alan |
|
2012 |
14 |
3 |
p. 639-645 |
artikel |
27 |
Retraction note to: Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy
|
Dickerson, Tobin J. |
|
2012 |
14 |
3 |
p. 542 |
artikel |
28 |
Stability of Amorphous Pharmaceutical Solids: Crystal Growth Mechanisms and Effect of Polymer Additives
|
Sun, Ye |
|
2012 |
14 |
3 |
p. 380-388 |
artikel |
29 |
Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence
|
Polli, James E. |
|
2012 |
14 |
3 |
p. 627-638 |
artikel |
30 |
The Use of Modeling Tools to Drive Efficient Oral Product Design
|
Mathias, Neil R. |
|
2012 |
14 |
3 |
p. 591-600 |
artikel |
31 |
Tissue Distribution Studies of Protein Therapeutics Using Molecular Probes: Molecular Imaging
|
Williams, Simon-Peter |
|
2012 |
14 |
3 |
p. 389-399 |
artikel |
32 |
Toward Global Standards for Comparator Pharmaceutical Products: Case Studies of Amoxicillin, Metronidazole, and Zidovudine in the Americas
|
Löbenberg, Raimar |
|
2012 |
14 |
3 |
p. 462-472 |
artikel |
33 |
What about Pain in Disorders of Consciousness?
|
Schnakers, C. |
|
2012 |
14 |
3 |
p. 437-444 |
artikel |